Skip to content

Therapeutic Effects of Monochromatic Infrared Energy Therapy on Patients With Chronic Low Back Pain

Therapeutic Effects of Monochromatic Infrared Energy Therapy on Patients With Chronic Low Back Pain: A Double-Blind, Randomized, Placebo-Controlled Study

Status
UNKNOWN
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01920971
Enrollment
70
Registered
2013-08-12
Start date
2013-08-31
Completion date
2014-07-31
Last updated
2013-08-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Low Back Pain

Keywords

chronic low back pain, infrared energy, effects

Brief summary

To investigate the effects of short-term and medium-term monochromatic infrared energy therapy on patients with chronic low back pain (LBP) according to the International Classification of Functioning, Disability and Health.

Detailed description

Methods:70 participants with chronic LBP will be included. Participants received six 40-min sessions of hot pack therapy combined active or placebo monochromatic infrared energy therapy over the low back (wavelength = 890 nm, radiant power output = 6.24 W, power density = 34.7 milliwatt/cm2 for 40 min, total energy 83.2 J/cm2) followed by 20-min supervised therapeutic exercise, for 3 times per week for a 4-week duration. Patients will be assessed at before treatment and follow-up assessments, including after 2 week of treatment; after 4 weeks of treatment; and 1 and 3 months, respectively, after treatment is terminated. Main Outcome Measures: Patients will be assessed periodically with pain, Multidimensional Fatigue Inventory, postural stability (using the postural stability evaluation system: Biodex Stability System), and Fear-Avoidance Behavior Questionnaire.

Interventions

wavelength = 890 nm, radiant power output = 6.24 W, power density = 34.7 milliWatts/cm2 for 40 min, total energy 83.2 J/cm2

Sponsors

National Science and Technology Council, Taiwan
CollaboratorOTHER_GOV
Taipei Medical University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
20 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

participants with chronic low back pain

Exclusion criteria

1. low back pain accompanied by specific pathological conditions, such as an infection,inflammation, rheumatoid arthritis, fracture, or tumor; 2. a self-reported history of malignancy, vertigo, stroke, or other condition that may impair postural stability; 3. a history of low back surgery with an implant; 4. pregnancy or plans to become pregnant during the course of the study; 5. having received concurrent treatment for low back pain by another health care professional

Design outcomes

Primary

MeasureTime frameDescription
changes of painparticipants will be evaluated at before treatment, and followed at treatment for 2 and 4 weeks, and 1 and 3 months after treatmentParticipants received six 40-min sessions of hot pack therapy combined active or placebo monochromatic infrared energy therapy over the low back (wavelength = 890 nm, radiant power output = 6.24 W, power density = 34.7 milliWatts/cm2 for 40 min, total energy 83.2 J/cm2) followed by 20-min supervised therapeutic exercise, for 3 times per week for a 4-week duration.

Secondary

MeasureTime frameDescription
changes of Multidimensional Fatigue Inventoryparticipants will be evaluated at before treatment, and followed at treatment for 2 and 4 weeks, and 1 and 3 months after treatment
changes of postural stabilityparticipants will be evaluated at before treatment, and followed at treatment for 2 and 4 weeks, and 1 and 3 months after treatmentusing the postural stability evaluation system: Biodex Stability System
changes of fear avoidance behaviorparticipants will be evaluated at before treatment, and followed at treatment for 2 and 4 weeks, and 1 and 3 months after treatmentusing Fear-Avoidance Behavior Questionnaire

Countries

Taiwan

Contacts

Primary ContactRu-Lan Hsieh, MD
M001052@ms.skh.org.tw886-2-28332211

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026